← ANALYST RATINGS · TIPRANKS
ICU Medical (ICUI): analyst forecast and price target
Analyst consensus
Strong Buy4 Buy0 Hold0 Sell
Ratings of 4 analysts in the last 3 months12-month forecast
Based on 4 price targets given in the last 3 months, the average target is $196, the highest $200, the lowest $187. The average is +19.9% from the last price of $163.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - Instruments and SuppliesxAI Grok-3 | TipRanks - xAI | $178 → $181+1.7% | Buy | +11.0% | Upgrade | 15.10.26on TipRanks Oct 14 23:05 | — | |
| AI DeepSeek Medical - Instruments and SuppliesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $172 → $175+1.7% | Hold | +7.4% | Reiterated | 15.10.26on TipRanks Oct 14 23:05 | — | |
| AI OpenAI Medical - Instruments and SuppliesOpenAI 5.2 | TipRanks - OpenAI | $172 → $175+1.7% | Hold | +7.4% | Reiterated | 15.10.26on TipRanks Oct 14 23:05 | — | |
| AI Anthropic Medical - Instruments and SuppliesAnthropic Opus-4.5 | TipRanks - Anthropic | $163 → $166+1.8% | Hold | +1.8% | Reiterated | 15.10.26on TipRanks Oct 14 23:05 | — | |
| AI Google Medical - Instruments and SuppliesGemini 3-pro | TipRanks - Google | $181 → $184+1.7% | Buy | +12.9% | Reiterated | 15.10.26on TipRanks Oct 14 23:05 | — | |
| AI PerPlexity Medical - Instruments and SuppliesPerPlexity SonarPro | TipRanks - PerPlexity | $166 → $169+1.8% | Hold | +3.7% | Reiterated | 15.10.26on TipRanks Oct 14 23:05 | — | |
| Jason Bednar★★★★★★★★★★#11450 · hits 46% · avg −2.5% | Piper Sandler | $195 | Buy | +19.6% | Reiterated | 23.09.26on TipRanks 07:10 | +2.2%next day +1.7% · 5 days −1.0% | ↗ |
| Jayson Bedford★★★★★★★★★★#819 · hits 60% · avg +8.6% | Raymond James | $200 | Buy | +22.7% | Reiterated | 07.08.26on TipRanks 09:50 | +10.3%next day −1.1% · 5 days −1.3% | ↗ |
| Sam Eiber★★★★★★★★★★#4161 · hits 53% · avg +8.6% | BTIG | $170 → $200+17.6% | Buy | +22.7% | Assigned | 07.08.26on TipRanks 07:01 | +10.3%next day −1.1% · 5 days −1.3% | ↗ |
| Michael Matson★★★★★★★★★★#1853 · hits 50% · avg +6.0% | Needham | $165 → $187+13.3% | Buy | +14.7% | Assigned | 07.08.26on TipRanks 03:15 | +10.3%next day −1.1% · 5 days −1.3% | ↗ |
| Michael Toomey★★★★★★★★★★#10023 · hits 29% · avg −6.8% | Jefferies | $175 | Buy | +7.4% | Reiterated | 16.07.26on TipRanks Jul 15 23:06 | +3.2%next day −1.9% · 5 days −3.7% | ↗ |
| Brett Fishbin★★★★★★★★★★#10514 · hits 45% · avg −3.0% | KeyBanc | $164 | Buy | +0.6% | Reiterated | 08.05.26on TipRanks 05:30 | +1.9%next day −1.6% · 5 days −6.3% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering ICU Medical
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $191 at a price of $161 (+19.2%); now: $196 at $163 (+19.9%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 7 | 8 | 7 | 7 | 7 | 6 |
| Hold | 2 | 2 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 09.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $2.14 (from $2.12 to $2.16). Last quarter: $2.37.
Sales
Next quarter’s sales estimate — $552M (from $550M to $559M). Last quarter: $552M.
Best top-analyst consensus in the sector · Healthcare
About ICU Medical
- CEO: Vivek Jain
- Employees: 13,000
- 951 Calle Amanecer, San Clemente, CA, 92673, US
- www.icumed.com
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home
Data from the stock’s TipRanks forecast page, read 90 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗